Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 19.31%2.95B | 11.66%5.39B | 5.63%2.47B | -12.00%4.82B | -21.96%2.34B | -13.85%5.48B | -9.61%3B | 41.75%6.36B | 88.04%3.32B | 23.44%4.49B |
| Operating income | 19.31%2.95B | 11.66%5.39B | 5.63%2.47B | -12.00%4.82B | -21.96%2.34B | -13.85%5.48B | -9.61%3B | 41.75%6.36B | 88.04%3.32B | 23.44%4.49B |
| Cost of sales | -22.97%-2.42B | -10.76%-4.34B | -2.00%-1.97B | 14.22%-3.92B | 24.20%-1.93B | 13.90%-4.57B | 7.34%-2.55B | -44.82%-5.3B | -88.59%-2.75B | -21.92%-3.66B |
| Operating expenses | -22.97%-2.42B | -10.76%-4.34B | -2.00%-1.97B | 14.22%-3.92B | 24.20%-1.93B | 13.90%-4.57B | 7.34%-2.55B | -44.82%-5.3B | -88.59%-2.75B | -21.92%-3.66B |
| Gross profit | 4.94%526.66M | 15.54%1.05B | 22.75%501.85M | -0.94%907.2M | -9.31%408.84M | -13.63%915.78M | -20.56%450.83M | 28.16%1.06B | 85.40%567.52M | 30.66%827.34M |
| Selling expenses | 18.41%-68.6M | 1.39%-178.31M | 6.38%-84.08M | 6.95%-180.83M | 18.95%-89.81M | 11.74%-194.34M | 12.55%-110.81M | -41.44%-220.19M | -62.19%-126.7M | -5.14%-155.68M |
| Administrative expenses | 2.17%-241.85M | -21.57%-506.22M | -37.67%-247.22M | -0.49%-416.39M | 16.55%-179.58M | -0.03%-414.38M | -14.03%-215.2M | -48.48%-414.23M | -57.46%-188.73M | -4.77%-278.98M |
| Impairment and provision | 87.06%-1.28M | -2,331.60%-10.31M | -57.13%-9.86M | 58.99%-424K | -18,547.06%-6.27M | 42.43%-1.03M | -93.25%34K | -29.86%-1.8M | 165.12%504K | -353.44%-1.38M |
| -Other impairment is provision | 87.06%-1.28M | -2,331.60%-10.31M | -57.13%-9.86M | 58.99%-424K | -18,547.06%-6.27M | 42.43%-1.03M | -93.25%34K | -29.86%-1.8M | 165.12%504K | -353.44%-1.38M |
| Special items of operating profit | -5.09%37.41M | -20.25%65.31M | 22.87%39.42M | 40.62%81.89M | -19.25%32.08M | 55.78%58.24M | 3,427.30%39.73M | 444.27%37.38M | -109.67%-1.19M | -279.99%-10.86M |
| Operating profit | 26.10%252.34M | 6.94%418.62M | 21.09%200.11M | 7.46%391.45M | 0.41%165.25M | -21.07%364.27M | -34.53%164.58M | 21.30%461.49M | 110.03%251.39M | 69.41%380.45M |
| Financing income | -11.19%8.02M | 134.81%17.1M | 339.45%9.04M | 252.30%7.28M | 111.74%2.06M | -30.54%2.07M | -42.68%971K | 412.22%2.98M | 161.02%1.69M | -5.53%581K |
| Financing cost | -232.66%-7.06M | 20.09%-8.67M | 63.93%-2.12M | 25.46%-10.85M | -7.06%-5.88M | -94.50%-14.56M | -19.56%-5.5M | -3.90%-7.49M | -3.05%-4.6M | 12.90%-7.21M |
| Earning before tax | 22.36%253.31M | 10.10%427.05M | 28.25%207.02M | 10.26%387.88M | 0.86%161.43M | -23.02%351.78M | -35.59%160.06M | 22.24%456.98M | 114.44%248.49M | 72.33%373.82M |
| Tax | -29.83%-41.13M | 27.18%-43.46M | -26.89%-31.68M | -8.02%-59.68M | 9.46%-24.97M | 19.30%-55.25M | 48.49%-27.58M | 19.64%-68.46M | -154.94%-53.54M | -110.55%-85.19M |
| After-tax profit from continuing operations | 21.01%212.18M | 16.88%383.59M | 28.50%175.34M | 10.68%328.2M | 3.00%136.46M | -23.68%296.53M | -32.05%132.48M | 34.61%388.52M | 105.47%194.96M | 63.57%288.63M |
| Earning after tax | 21.01%212.18M | 16.88%383.59M | 28.50%175.34M | 10.68%328.2M | 3.00%136.46M | -23.68%296.53M | -32.05%132.48M | 34.61%388.52M | 105.47%194.96M | 63.57%288.63M |
| Minority profit | 209.05%530K | 53.52%-304K | -92.09%-486K | -76.28%-654K | 54.41%-253K | -103.75%-371K | -111.65%-555K | 2,429.18%9.9M | 2,235.43%4.76M | -45.05%-425K |
| Profit attributable to shareholders | 20.37%211.65M | 16.74%383.9M | 28.61%175.83M | 10.76%328.86M | 2.76%136.71M | -21.58%296.9M | -30.05%133.03M | 30.98%378.62M | 99.98%190.2M | 63.54%289.06M |
| Basic earnings per share | 23.53%0.21 | 16.93%0.373 | 30.77%0.17 | 8.87%0.319 | 0.00%0.13 | -22.49%0.293 | -31.58%0.13 | 30.80%0.378 | 90.00%0.19 | 63.28%0.289 |
| Diluted earnings per share | 23.53%0.21 | 16.93%0.373 | 30.77%0.17 | 8.87%0.319 | 0.00%0.13 | -22.49%0.293 | -31.58%0.13 | 30.80%0.378 | 90.00%0.19 | 63.28%0.289 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.